Sartorius (OTCMKTS:SARTF) Sees Large Decline in Short Interest

Sartorius (OTCMKTS:SARTF) was the target of a significant decline in short interest in July. As of July 31st, there was short interest totaling 458 shares, a decline of 49.9% from the July 15th total of 915 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days. Approximately 0.0% of the company’s stock are short sold.

Sartorius Stock Performance

Shares of SARTF stock remained flat at $212.80 during trading hours on Monday. The company’s 50-day moving average price is $211.83 and its two-hundred day moving average price is $218.57. Sartorius has a 12 month low of $181.58 and a 12 month high of $227.00. The firm has a market cap of $7.28 billion, a PE ratio of 98.98 and a beta of 0.98. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49.

Sartorius Company Profile

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.